Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by Pareto8020on Nov 30, 2020 4:27pm
95 Views
Post# 32002974

RE:RE:RE:Solid Update

RE:RE:RE:Solid UpdateWell that news release just pushed SBM to the brink of some 52 week lows.  This is where SBM was trading 4 years ago!  Something has to change and I think #1 is get Howie the hell out of the drivers seat.  All he has done is stalled things while trying to figure out how biotech works. 

Go back to being a full time doc - we need those right now and your skills would be better put to use helping those in need vs. us shareholders in need.  I honestly can't wait for some kind of revenue event to finally occur so I can exit this play stage left.  It's just not worth the frustration after all these years of watching Howie and crew fumbling from deal to deal, creating next to no revenue and repeating the same promises and tired old excuses on every video and news release.  
<< Previous
Bullboard Posts
Next >>